Volunteers in a new trial to gauge the efficacy of the Astra-Zeneca vaccine in younger patients received their first doses yesterday.
They spoke about the experience, and why they volunteered.
Report by Odonovanc.
Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
